Hosp Pharm. 1981 Jan;16(1):17-20.
The Specialty Practice Committee on Parenteral Services is one of a number of subcommittees of the Federal Council of The Society of Hospital Pharmacists of Australia (SHPA) having responsibility for development of professional practice in particular areas, such as drug distribution, drug information, clinical pharmacy, radiopharmaceuticals, and a number of others. Parenteral Services has been, perhaps, the major area of growth in Australian hospital pharmacy over the last three years. The pattern of growth of Australia has deviated somewhat from that which has emerged in the United States. Whereas the typical I.V. admixture service is relatively uncommon in Australian hospitals, the emphasis is towards specialization into Parenteral Nutrition and Oncology Support Services. Developments in Oncology Support have been particularly rapid, with many pharmacists becoming exclusively involved in this specialty. Concern is felt that operators intensively reconstituting and preparing cytotoxic drugs may be at risk from a variety of factors. Australian hospital pharmacists share the growing international opinion that this work is potentially hazardous and that safety guidelines governing every aspect of handling these substances are urgently required. The Specialty Practice Committee on Parenteral Services has conducted a study of safety aspects of this work as its major project for 1980 and has produced the document presented below. This is an official statement of the Society of Hospital Pharmacists of Australia.
澳大利亚医院药剂师协会（SHPA）联邦委员会的多个小组委员会之一是胃肠外服务专业实践委员会，该委员会负责特定领域专业实践的发展，如药品分发、药品信息、临床药学、放射性药物等多个领域。在过去三年里，胃肠外服务可能一直是澳大利亚医院药学领域的主要增长领域。澳大利亚的增长模式与美国出现的模式略有不同。在美国，典型的静脉药物混合服务在澳大利亚医院相对不常见，重点是转向胃肠外营养和肿瘤支持服务的专业化。肿瘤支持领域的发展尤其迅速，许多药剂师专门从事这一专业。人们担心，大量重新配制和准备细胞毒性药物的操作人员可能面临多种因素的风险。澳大利亚医院药剂师认同国际上越来越多的观点，即这项工作存在潜在危险，迫切需要制定管理这些物质处理各个方面的安全指南。胃肠外服务专业实践委员会将这项工作的安全方面研究作为其1980年的主要项目，并编制了以下文件。这是澳大利亚医院药剂师协会的官方声明。
